by Devices and Pharma | Jun 24, 2026 | Consumer Information, Drug Warning Letters, Industry Information, Industry News, Pharmaceutical Labeling, Products_Drugs, Unapproved Drugs, US-FDA
FDA Warning Letters Wild Arabic Herbs “Edral-17t” product an unapproved new drug Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central...
by Devices and Pharma | Jun 24, 2026 | Consumer Information, Drug Warning Letters, FDA Public Information, Industry Information, Industry News, Pharmaceutical Labeling, Products_Drugs, Unapproved Drugs, US-FDA
FDA Warning Letters Unapproved drugs marketed on Amazon.com website Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News...
by Devices and Pharma | May 16, 2026 | Consumer Information, Dietary Supplements, Gas Station Drugs, Industry Information, Industry News, Labeling, Pharmaceutical Labeling, Pharmaceuticals, Product Ingredients, Unapproved Drugs
Drug Safety Information The wild west environment for "gas station" drugs Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News...
by Bruce Waldon | Mar 4, 2026 | Compounding Labs, Drug Warning Letters, Industry Information, Industry News, Pharmaceutical Labeling, Pharmaceuticals, Telehealth, US-FDA
MDP Regulatory Insight FDA warns about compounded GLP-1 marketing claims Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA Issues 30 Warning Letters to...
